AAPL Apple | Target Raised by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $210.62 -1.6% | $200.00 ➝ $250.00 | Outperform ➝ Outperform | |
ACCD Accolade | Target Lowered by | Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.58 -44.0% | $13.00 ➝ $6.00 | Buy ➝ Buy | |
ACCD Accolade | Target Lowered by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.58 -44.0% | $13.00 ➝ $8.00 | Buy ➝ Buy | |
ACCD Accolade | Target Lowered by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.58 -44.0% | $14.00 ➝ $9.00 | Buy ➝ Buy | |
ACCD Accolade | Target Lowered by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.58 -44.0% | $12.00 ➝ $6.00 | Equal Weight ➝ Equal Weight | |
ACCD Accolade | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.58 -44.0% | $11.00 ➝ $5.50 | Equal Weight ➝ Equal Weight | |
Elon Musk: THIS will be bigger than Tesla (Ad) If you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you must get in now. Don’t delay. See all the details you need here. |
ACCD Accolade | Target Lowered by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.58 -44.0% | $16.00 ➝ $13.00 | Buy ➝ Buy | |
ADAG Adagene | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.06 -0.6% | $5.00 ➝ $5.00 | Buy ➝ Buy | |
ADUS Addus HomeCare | Initiated by | Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $116.11 +1.7% | $136.00 | Outperform | |
AFG American Financial Group | Downgraded by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | C. Lederer Subscribe to MarketBeat All Access for the recommendation accuracy rating | $123.02 -1.9% | $144.00 ➝ $137.00 | Buy ➝ Neutral | |
AFL Aflac | Target Raised by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $89.31 +0.2% | $95.00 ➝ $100.00 | Overweight ➝ Overweight | |
AFL Aflac | Target Lowered by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $89.31 +0.2% | $84.00 ➝ $83.00 | Hold ➝ Hold | |
AFRM Affirm | Initiated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $30.21 -0.8% | | Market Perform | |
AGCO AGCO | Target Lowered by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $97.88 -1.0% | $135.00 ➝ $130.00 | Overweight ➝ Overweight | |
AGCO AGCO | Initiated by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $97.88 -1.0% | | Market Perform | |
AGEN Agenus | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.75 +18.6% | $40.00 ➝ $40.00 | Buy ➝ Buy | |
AIZ Assurant | Reiterated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $166.25 -0.6% | $205.00 ➝ $205.00 | Overweight ➝ Overweight | |
AKT.A AKITA Drilling | Target Lowered by | ATB Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | C$1.34 +1.5% | C$3.75 ➝ C$3.25 | Outperform | |
ALNY Alnylam Pharmaceuticals | Target Raised by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $243.00 -1.6% | $253.00 ➝ $288.00 | Buy ➝ Buy | |
ALSN Allison Transmission | Initiated by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | T. Thein Subscribe to MarketBeat All Access for the recommendation accuracy rating | $75.90 +2.2% | $85.00 | Outperform | |
AMCR Amcor | Initiated by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.78 -0.3% | $9.80 | Equal Weight | |
AMLI American Lithium | Target Lowered by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.56 -1.8% | $5.50 ➝ $3.25 | Buy ➝ Buy | |
AMP Ameriprise Financial | Target Lowered by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $427.19 -0.7% | $390.00 ➝ $387.00 | Underweight ➝ Underweight | |
AMP Ameriprise Financial | Target Raised by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $427.19 -0.7% | $500.00 ➝ $504.00 | Buy ➝ Buy | |
AMZN Amazon.com | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $193.25 -2.3% | $234.00 ➝ $239.00 | Overweight ➝ Overweight | |
AOSL Alpha and Omega Semiconductor | Target Raised by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.37 +4.5% | $28.00 ➝ $42.00 | Buy ➝ Buy | |
APLD Applied Digital | Target Raised by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.95 -4.6% | $6.00 ➝ $8.00 | Buy ➝ Buy | |
APLS Apellis Pharmaceuticals | Reiterated by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.36 -7.6% | $100.00 ➝ $100.00 | Outperform ➝ Outperform | |
APOG Apogee Enterprises | Target Raised by | DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $62.84 -1.9% | $60.00 ➝ $65.00 | Neutral ➝ Neutral | |
ARX ARC Resources | Target Raised by | ATB Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | C$24.41 -0.9% | C$26.00 ➝ C$27.00 | | |
ATOS Atossa Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | E. Bodnar Subscribe to MarketBeat All Access for the recommendation accuracy rating | $1.19 +4.4% | $6.00 ➝ $6.00 | Buy ➝ Buy | |
AVTR Avantor | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.20 -1.0% | $28.00 ➝ $25.00 | Overweight ➝ Overweight | |
AYI Acuity Brands | Downgraded by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. O'dea Subscribe to MarketBeat All Access for the recommendation accuracy rating | $241.44 -0.4% | $295.00 ➝ $260.00 | Overweight ➝ Equal Weight | |
BB BlackBerry | Target Lowered by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.48 +1.2% | $5.50 ➝ $4.75 | Market Perform ➝ Market Perform | |
BCF Builders Capital Mortgage | Target Set by | Fundamental Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | C$8.50 -0.6% | C$10.50 | Buy | |
BHF Brighthouse Financial | Target Lowered by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $43.34 -0.5% | $50.00 ➝ $45.00 | Neutral ➝ Neutral | |
BHF Brighthouse Financial | Target Raised by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $43.34 -0.5% | $46.00 ➝ $49.00 | Hold ➝ Hold | |
BIIB Biogen | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $231.82 +1.4% | $294.00 ➝ $294.00 | Buy ➝ Buy | |
BKD Brookdale Senior Living | Initiated by | Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.83 +3.2% | $7.50 | Outperform | |
BKR Baker Hughes | Target Raised by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $35.17 +2.2% | $45.00 ➝ $46.00 | Buy ➝ Buy | |
Elon Musk: “This Could be Massive…a Multi Trillion-Dollar Company.” (Ad) Have you seen Elon Musk’s latest crazy prediction? Click here to see it because he believes this new venture… |
BL BlackLine | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $48.45 +1.3% | $62.00 ➝ $54.00 | Neutral ➝ Neutral | |
BME B&M European Value Retail | Reiterated by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | GBX 437.20 -1.8% | | Underweight | |
BMRC Bank of Marin Bancorp | Reiterated by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.19 +0.7% | $21.00 ➝ $21.00 | Outperform ➝ Outperform | |
BNZL Bunzl | Target Raised by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | GBX 3,010 -2.0% | GBX 3,300 ➝ GBX 3,380 | Neutral | |
BNZL Bunzl | Reiterated by | Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | | GBX 3,010 -2.0% | GBX 3,200 | Hold | |
BPMC Blueprint Medicines | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $107.78 -0.7% | $130.00 ➝ $130.00 | Buy ➝ Buy | |
BR Broadridge Financial Solutions | Reiterated by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $197.00 -1.1% | $239.00 ➝ $239.00 | Outperform ➝ Outperform | |
BWIN The Baldwin Insurance Group | Target Raised by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $35.47 +1.3% | $34.00 ➝ $40.00 | Outperform ➝ Outperform | |
CAG Conagra Brands | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.42 +0.3% | $32.00 ➝ $30.00 | Neutral ➝ Neutral | |
CAT Caterpillar | Initiated by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $333.10 +1.7% | | Market Perform | |
CB Chubb | Downgraded by | William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $255.08 -2.7% | | Market Perform ➝ Underperform | |
CB Chubb | Reiterated by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $255.08 -2.7% | $285.00 ➝ $285.00 | Outperform ➝ Outperform | |
CERT Certara | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.85 +1.5% | $18.00 ➝ $16.00 | Equal Weight ➝ Equal Weight | |
CET Cathedral Energy Services | Target Lowered by | ATB Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | C$0.89 -1.1% | C$1.60 ➝ C$1.50 | Outperform | |
CEU CES Energy Solutions | Target Raised by | ATB Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | C$7.70 +4.1% | C$8.25 ➝ C$8.50 | Outperform | |
CGON CG Oncology | Initiated by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.57 +4.4% | $65.00 | Buy | |
CHPT ChargePoint | Target Lowered by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.51
| $4.25 ➝ $3.00 | Buy ➝ Buy | |
CHWY Chewy | Target Raised by | Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.24 -6.2% | $25.00 ➝ $32.00 | Buy ➝ Buy | |
CINF Cincinnati Financial | Upgraded by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | C. Lederer Subscribe to MarketBeat All Access for the recommendation accuracy rating | $118.10 +1.2% | $126.00 ➝ $135.00 | Neutral ➝ Buy | |
CLSK CleanSpark | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.95 -0.6% | $27.00 ➝ $27.00 | Buy ➝ Buy | |
CMG Chipotle Mexican Grill | Reiterated by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $62.65 +0.4% | $67.00 ➝ $70.00 | Outperform ➝ Outperform | |
CMI Cummins | Initiated by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $276.93 -1.3% | | Market Perform | |
CNO CNO Financial Group | Target Raised by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.72 +0.6% | $29.00 ➝ $31.00 | Overweight ➝ Overweight | |
CRBG Corebridge Financial | Target Raised by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.12 +0.0% | $35.00 ➝ $40.00 | Buy ➝ Buy | |
CRBG Corebridge Financial | Reiterated by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.12 +0.0% | $33.00 ➝ $33.00 | Outperform ➝ Outperform | |
CRL Charles River Laboratories International | Reiterated by | Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating | D. Toung Subscribe to MarketBeat All Access for the recommendation accuracy rating | $206.58 -0.4% | | Buy ➝ Hold | |
CRL Charles River Laboratories International | Initiated by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $206.58 -0.4% | $230.00 | Equal Weight | |
CRNX Crinetics Pharmaceuticals | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $44.79 +3.0% | $60.00 ➝ $60.00 | Buy ➝ Buy | |
CRSP CRISPR Therapeutics | Reiterated by | Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating | D. Chattopadhyay Subscribe to MarketBeat All Access for the recommendation accuracy rating | $54.01 -2.5% | | Neutral | |
CSH.UN Chartwell Retirement Residences | Target Set by | TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | C$12.85 +0.8% | C$16.00 | Buy | |
CSH.UN Chartwell Retirement Residences | Target Raised by | Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating | | C$12.85 +0.8% | C$14.00 ➝ C$15.00 | Outperform | |
CSH.UN Chartwell Retirement Residences | Target Set by | Desjardins Subscribe to MarketBeat All Access for the recommendation accuracy rating | | C$12.85 +0.8% | C$15.50 | Buy | |
CTLT Catalent | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $56.23 -0.3% | $47.00 ➝ $63.00 | Equal Weight ➝ Equal Weight | |
CURY Currys | Reiterated by | Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | | GBX 72 +0.5% | GBX 80 | Hold | |
CURY Currys | Target Raised by | Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating | | GBX 72 +0.5% | GBX 90 ➝ GBX 92 | Buy | |
DAL Delta Air Lines | Target Lowered by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $47.44 -2.4% | $58.00 ➝ $56.00 | Buy ➝ Buy | |
DAY Dayforce | Target Lowered by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $49.60 -0.2% | $63.00 ➝ $53.00 | Buy ➝ Buy | |
DCI Donaldson | Initiated by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $71.56 +0.4% | | Market Perform | |
DCOM Dime Community Bancshares | Reiterated by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $20.40 +1.8% | $25.50 ➝ $25.50 | Outperform ➝ Outperform | |
DCTH Delcath Systems | Initiated by | Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating | C. Knickerbocker Subscribe to MarketBeat All Access for the recommendation accuracy rating | $8.37 +1.7% | $18.00 | Buy | |
DE Deere & Company | Initiated by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $373.63 -0.4% | $420.00 | Outperform | |
DERM Journey Medical | Initiated by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.64 +9.7% | $11.00 | Buy | |
DERM Journey Medical | Upgraded by | Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Wittes Subscribe to MarketBeat All Access for the recommendation accuracy rating | $5.64 +9.7% | | Strong-Buy | |
DG Dollar General | Target Raised by | Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $132.23 +1.5% | $135.00 ➝ $140.00 | Hold ➝ Hold | |
DLR Digital Realty Trust | Upgraded by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $152.05 +2.2% | $150.00 ➝ $175.00 | Neutral ➝ Overweight | |
DLTR Dollar Tree | Target Lowered by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $106.77 +1.5% | $170.00 ➝ $155.00 | Buy ➝ Buy | |
DVAX Dynavax Technologies | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.23 -1.2% | $29.00 ➝ $29.00 | Buy ➝ Buy | |
EDSA Edesa Biotech | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.28
| $21.00 ➝ $21.00 | Buy ➝ Buy | |
EFX Enerflex | Target Lowered by | ATB Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | C$7.38 +1.9% | C$12.50 ➝ C$12.00 | Outperform | |
ELAN Elanco Animal Health | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.43 +1.1% | $23.00 ➝ $21.00 | Overweight ➝ Overweight | |
Elon Musk: THIS will be bigger than Tesla (Ad) If you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you must get in now. Don’t delay. See all the details you need here. |
ELEV Elevation Oncology | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.70 +7.6% | $7.00 ➝ $7.00 | Market Outperform ➝ Market Outperform | |
ENSG The Ensign Group | Initiated by | Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $123.69 +2.4% | $134.00 | Outperform | |
EOSE Eos Energy Enterprises | Reiterated by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.27 -6.6% | $4.50 ➝ $4.50 | Buy ➝ Buy | |
EPRT Essential Properties Realty Trust | Initiated by | The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | C. Burrows Subscribe to MarketBeat All Access for the recommendation accuracy rating | $27.71 +1.5% | $33.00 | Buy | |
EQH Equitable | Target Raised by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $40.86 +0.9% | $46.00 ➝ $51.00 | Buy ➝ Buy | |
EQR Equity Residential | Upgraded by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $69.34 +1.5% | $70.00 ➝ $80.00 | Neutral ➝ Overweight | |
ESPR Esperion Therapeutics | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.22 -3.9% | $8.00 ➝ $8.00 | Buy ➝ Buy | |
ESPR Esperion Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.22 -3.9% | $16.00 ➝ $16.00 | Buy ➝ Buy | |
ESS Essex Property Trust | Reiterated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $272.20 +0.5% | $315.00 ➝ $315.00 | Overweight ➝ Overweight | |
ETN Eaton | Initiated by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $313.55 -0.1% | $375.00 | Outperform | |
EYPT EyePoint Pharmaceuticals | Reiterated by | Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.70 -0.6% | $28.00 ➝ $28.00 | Buy ➝ Buy | |
FCBC First Community Bankshares | Initiated by | Hovde Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | B. Rabatin Subscribe to MarketBeat All Access for the recommendation accuracy rating | $36.84 +2.9% | $38.00 | Market Perform | |
FG F&G Annuities & Life | Target Lowered by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.05 -2.0% | $43.00 ➝ $42.00 | Neutral ➝ Neutral | |
FIZZ National Beverage | Target Raised by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $51.24 +1.0% | $47.00 ➝ $48.00 | Sell ➝ Sell | |
FSG Foresight Group | Reiterated by | Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | | GBX 470 +2.0% | GBX 600 | Buy | |
FSLR First Solar | Target Raised by | Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $225.46 -9.8% | $215.00 ➝ $280.00 | Buy ➝ Buy | |
FT Fortune Minerals | Target Set by | Fundamental Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | C$0.09
| C$0.35 | Buy | |
GE General Electric | Target Raised by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $158.97 -1.0% | $185.00 ➝ $190.00 | Buy ➝ Buy | |
GEI Gibson Energy | Target Raised by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | C$23.25 +0.1% | C$26.00 ➝ C$27.00 | Overweight | |
GH Guardant Health | Upgraded by | Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating | S. Nambi Subscribe to MarketBeat All Access for the recommendation accuracy rating | $28.88 -0.6% | $36.00 | Neutral ➝ Buy | |
GHLD Guild | Target Raised by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.79 -4.9% | $14.00 ➝ $16.50 | Market Outperform ➝ Market Outperform | |
GIS General Mills | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $63.26 -0.7% | $72.00 ➝ $67.00 | Equal Weight ➝ Equal Weight | |
GIS General Mills | Target Lowered by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $63.26 -0.7% | $76.00 ➝ $72.00 | In-Line ➝ In-Line | |
GL Globe Life | Target Lowered by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $82.28 +0.0% | $110.00 ➝ $105.00 | Overweight ➝ Overweight | |
GL Globe Life | Target Raised by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $82.28 +0.0% | $85.00 ➝ $88.00 | Hold ➝ Hold | |
GLUE Monte Rosa Therapeutics | Reiterated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.74 +10.7% | $16.00 ➝ $16.00 | Overweight ➝ Overweight | |
GNL Global Net Lease | Reiterated by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.35 +2.2% | $11.00 ➝ $11.00 | Outperform ➝ Outperform | |
GOOG Alphabet | Downgraded by | Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | B. Crockett Subscribe to MarketBeat All Access for the recommendation accuracy rating | $183.42 -1.8% | $181.00 | Buy ➝ Neutral | |
GOOGL Alphabet | Reiterated by | Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | B. Crockett Subscribe to MarketBeat All Access for the recommendation accuracy rating | $182.15 -1.8% | $182.00 ➝ $181.00 | Buy ➝ Neutral | |
GOOGL Alphabet | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $182.15 -1.8% | $210.00 ➝ $210.00 | Buy ➝ Buy | |
GSHD Goosehead Insurance | Reiterated by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $57.44 -0.2% | $80.00 ➝ $80.00 | Outperform ➝ Outperform | |
GSK GSK | Reiterated by | Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | | GBX 1,529.50 +0.2% | GBX 1,950 | Buy | |
GTLB GitLab | Reiterated by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $49.72 +0.5% | $65.00 ➝ $65.00 | Outperform ➝ Outperform | |
HAL Halliburton | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $33.78 +0.5% | $50.00 ➝ $45.00 | Buy ➝ Buy | |
HCA HCA Healthcare | Target Raised by | Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $321.28 -6.4% | $359.00 ➝ $375.00 | Buy ➝ Buy | |
HEES H&E Equipment Services | Initiated by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $44.17 +0.8% | | Market Perform | |
HIG The Hartford Financial Services Group | Reiterated by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $100.54 -2.2% | $105.00 ➝ $105.00 | Sector Perform ➝ Sector Perform | |
HIG The Hartford Financial Services Group | Downgraded by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $100.54 -2.2% | $116.00 ➝ $114.00 | Buy ➝ Neutral | |
HLMA Halma | Reiterated by | Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | | GBX 2,706 -0.6% | GBX 2,400 | Hold | |
HMN Horace Mann Educators | Target Lowered by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $32.62 -1.4% | $37.00 ➝ $35.00 | Neutral ➝ Neutral | |
HXL Hexcel | Target Lowered by | Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $62.45 -1.8% | $70.00 ➝ $68.00 | Hold ➝ Hold | |
III 3i Group | Reiterated by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | GBX 3,066 +2.2% | | Overweight | |
INFN Infinera | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.09 +15.8% | $5.40 ➝ $6.65 | Equal Weight ➝ Equal Weight | |
INFN Infinera | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | R. Koontz Subscribe to MarketBeat All Access for the recommendation accuracy rating | $6.09 +15.8% | | Buy ➝ Hold | |
INSM Insmed | Target Raised by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $67.00 +0.1% | $62.00 ➝ $83.00 | Buy ➝ Buy | |
INTA Intapp | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $36.67 +1.7% | $52.00 ➝ $50.00 | Buy ➝ Buy | |
INTU Intuit | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $657.21 +0.9% | $727.00 ➝ $750.00 | Buy ➝ Buy | |
IOT Samsara | Reiterated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $33.70 +3.3% | $36.00 ➝ $36.00 | Neutral ➝ Neutral | |
IOT Samsara | Reiterated by | Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $33.70 +3.3% | $42.00 ➝ $42.00 | Buy ➝ Buy | |
IOT Samsara | Reiterated by | Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $33.70 +3.3% | $44.00 ➝ $44.00 | Outperform ➝ Outperform | |
I spent 44 years on Wall Street. If you knew what I know, you’d be terrified too. (Ad) The Most Important Presentation in America Right Now
"Most people won't know what to do when their savings run out... Or when the stocks in their portfolios fall by half," says Wall Street icon Louis Navellier. "It's going to affect everything about our normal way of life: Our money, the value of our homes, our ability to retire." When it makes landfall, it's impact will be more violent and more severe than any financial crisis we've ever seen… Click here to see his official warning. |
IOVA Iovance Biotherapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.02 +0.1% | $32.00 ➝ $32.00 | Buy ➝ Buy | |
IP International Paper | Upgraded by | Seaport Res Ptn Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Weintraub Subscribe to MarketBeat All Access for the recommendation accuracy rating | $43.15 -0.2% | | Hold ➝ Strong-Buy | |
IQV IQVIA | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $211.44 -0.6% | $275.00 ➝ $255.00 | Overweight ➝ Overweight | |
JXN Jackson Financial | Target Raised by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $74.26 +1.4% | $62.00 ➝ $70.00 | Hold ➝ Hold | |
KIDZ Kidoz | Target Set by | Fundamental Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | C$0.16 -13.9% | C$0.75 | Buy | |
KNT K92 Mining Inc. (KNT.V) | Target Raised by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | C$7.99
| C$11.50 ➝ C$13.75 | Buy | |
KPTI Karyopharm Therapeutics | Target Lowered by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.87 -11.3% | $8.00 ➝ $7.00 | Buy ➝ Buy | |
KRUS Kura Sushi USA | Target Lowered by | Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $63.09 -23.4% | $130.00 ➝ $120.00 | Buy ➝ Buy | |
KRUS Kura Sushi USA | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $63.09 -23.4% | $95.00 ➝ $65.00 | Equal Weight ➝ Equal Weight | |
KRUS Kura Sushi USA | Reiterated by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $63.09 -23.4% | $120.00 ➝ $90.00 | Buy ➝ Buy | |
KRUS Kura Sushi USA | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $63.09 -23.4% | $115.00 ➝ $115.00 | Buy ➝ Buy | |
KTOS Kratos Defense & Security Solutions | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $20.01 +0.2% | $25.00 ➝ $25.00 | Buy ➝ Buy | |
LGND Ligand Pharmaceuticals | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $84.26 +2.3% | $95.00 ➝ $95.00 | Buy ➝ Buy | |
LNC Lincoln National | Target Raised by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.10 -0.4% | $34.00 ➝ $38.00 | Buy ➝ Buy | |
LNC Lincoln National | Target Raised by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.10 -0.4% | $30.00 ➝ $34.00 | Neutral ➝ Neutral | |
LPTX Leap Therapeutics | Initiated by | Rodman & Renshaw Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.96 +10.7% | $8.00 | Buy | |
LUNR Intuitive Machines | Initiated by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.30 -6.8% | $8.00 | Buy | |
LYFT Lyft | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.10 +5.3% | $18.00 ➝ $17.00 | Equal Weight ➝ Equal Weight | |
MANH Manhattan Associates | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $246.68 -1.8% | $220.00 ➝ $257.00 | Neutral ➝ Neutral | |
MDGL Madrigal Pharmaceuticals | Initiated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | P. Agrawal Subscribe to MarketBeat All Access for the recommendation accuracy rating | $280.16 -1.9% | | Neutral | |
MEOH Methanex | Reiterated by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $48.26 +0.1% | $55.00 ➝ $55.00 | Sector Perform ➝ Sector Perform | |
MET MetLife | Target Lowered by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $70.19 -0.9% | $88.00 ➝ $83.00 | Buy ➝ Buy | |
MFC Manulife Financial | Target Raised by | TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | C$36.43 +0.4% | C$38.00 ➝ C$40.00 | Buy | |
MFC Manulife Financial | Target Raised by | TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $26.62 +0.5% | $38.00 ➝ $40.00 | Buy ➝ Buy | |
MIDD Middleby | Initiated by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $122.61 -1.6% | | Market Perform | |
MIRM Mirum Pharmaceuticals | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $34.19 +3.3% | $66.00 ➝ $66.00 | Buy ➝ Buy | |
MKS Marks and Spencer Group | Reiterated by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | GBX 286.50 -2.5% | | Overweight | |
MKS Marks and Spencer Group | Reiterated by | Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | | GBX 286.50 -2.5% | GBX 350 | Buy | |
MMC Marsh & McLennan Companies | Target Raised by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $210.72 -0.1% | $210.00 ➝ $228.00 | Sector Perform ➝ Sector Perform | |
MMSI Merit Medical Systems | Initiated by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $85.95 +3.0% | $96.00 | Outperform | |
MMSI Merit Medical Systems | Upgraded by | Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating | D. Rescott Subscribe to MarketBeat All Access for the recommendation accuracy rating | $85.95 +3.0% | | Strong-Buy | |
MOON Moonpig Group | Target Raised by | Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating | | GBX 190.60 +4.2% | GBX 265 ➝ GBX 280 | Buy | |
MRNA Moderna | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $118.75 -2.0% | | Hold | |
MRUS Merus | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $59.17 -1.7% | $92.00 ➝ $92.00 | Buy ➝ Buy | |
MURA Mural Oncology | Initiated by | Rodman & Renshaw Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.14 +2.3% | $15.00 | Buy | |
NFI NFI Group | Target Raised by | National Bankshares Subscribe to MarketBeat All Access for the recommendation accuracy rating | | C$15.84 +1.4% | C$19.00 ➝ C$21.00 | Outperform | |
NKE NIKE | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $75.37 -20.0% | $115.00 ➝ $92.00 | Overweight ➝ Overweight | |
NKE NIKE | Target Lowered by | Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $75.37 -20.0% | $130.00 ➝ $115.00 | Buy ➝ Buy | |
NKE NIKE | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $75.37 -20.0% | $115.00 ➝ $102.00 | Buy ➝ Buy | |
NKE NIKE | Target Lowered by | The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $75.37 -20.0% | $118.00 ➝ $105.00 | Buy ➝ Buy | |
NKE NIKE | Target Lowered by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $75.37 -20.0% | $113.00 ➝ $104.00 | Buy ➝ Buy | |
NKE NIKE | Reiterated by | KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $75.37 -20.0% | | Sector Weight | |
NKE NIKE | Target Lowered by | HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $75.37 -20.0% | $100.00 ➝ $90.00 | Hold ➝ Hold | |
NKE NIKE | Reiterated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $75.37 -20.0% | $120.00 ➝ $120.00 | Outperform ➝ Outperform | |
NKE NIKE | Target Lowered by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $75.37 -20.0% | $89.00 ➝ $75.00 | Hold ➝ Hold | |
NKE NIKE | Target Lowered by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $75.37 -20.0% | $125.00 ➝ $100.00 | Outperform ➝ Outperform | |
NKE NIKE | Target Lowered by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $75.37 -20.0% | $110.00 ➝ $105.00 | Outperform ➝ Outperform | |
NKE NIKE | Reiterated by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $75.37 -20.0% | $117.00 ➝ $88.00 | Buy ➝ Hold | |
NKE NIKE | Reiterated by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $75.37 -20.0% | $114.00 ➝ $79.00 | Overweight ➝ Equal Weight | |
NKE NIKE | Target Lowered by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $75.37 -20.0% | $115.00 ➝ $97.00 | Outperform ➝ Outperform | |
Elon Musk: THIS will be bigger than Tesla (Ad) If you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you must get in now. Don’t delay. See all the details you need here. |
NKE NIKE | Target Lowered by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $75.37 -20.0% | $115.00 ➝ $100.00 | Outperform ➝ Outperform | |
NKE NIKE | Reiterated by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Sole Subscribe to MarketBeat All Access for the recommendation accuracy rating | $75.37 -20.0% | $78.00 | Buy ➝ Neutral | |
NKE NIKE | Reiterated by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $75.37 -20.0% | $116.00 ➝ $83.00 | Overweight ➝ Neutral | |
NKE NIKE | Reiterated by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | R. Patel Subscribe to MarketBeat All Access for the recommendation accuracy rating | $75.37 -20.0% | | Outperform ➝ Market Perform | |
NKE NIKE | Downgraded by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $75.37 -20.0% | $109.00 ➝ $80.00 | Overweight ➝ Equal Weight | |
NKE NIKE | Target Lowered by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $75.37 -20.0% | $99.00 ➝ $81.00 | Hold ➝ Hold | |
NKE NIKE | Target Lowered by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $75.37 -20.0% | $118.00 ➝ $100.00 | Outperform ➝ Outperform | |
NKTR Nektar Therapeutics | Initiated by | Rodman & Renshaw Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.24 +8.8% | $2.00 | Buy | |
NKTX Nkarta | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.91 +0.9% | $13.00 ➝ $13.00 | Buy ➝ Buy | |
NXT Nextracker | Initiated by | Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating | B. Perincheril Subscribe to MarketBeat All Access for the recommendation accuracy rating | $46.88 -4.6% | $59.00 | Positive | |
OCDO Ocado Group | Target Lowered by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | GBX 288.90 +0.7% | GBX 450 ➝ GBX 380 | Neutral | |
ONT Oxford Nanopore Technologies | Reiterated by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | GBX 94.40 -3.7% | GBX 260 | Outperform | |
ORGO Organogenesis | Initiated by | Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | B. O'neil Subscribe to MarketBeat All Access for the recommendation accuracy rating | $2.80 +6.1% | $5.00 | Buy | |
ORRF Orrstown Financial Services | Initiated by | Janney Montgomery Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating | D. Cardenas Subscribe to MarketBeat All Access for the recommendation accuracy rating | $27.36 +4.1% | $32.00 | Buy | |
OSK Oshkosh | Initiated by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | T. Thein Subscribe to MarketBeat All Access for the recommendation accuracy rating | $108.20 +2.7% | $125.00 | Outperform | |
OWL Blue Owl Capital | Reiterated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.75 -0.8% | $23.00 ➝ $23.00 | Overweight ➝ Overweight | |
PACS PACS Group | Initiated by | Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.50 -2.3% | $35.00 | Outperform | |
PAYS Paysign | Reiterated by | Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.31 +7.5% | $7.00 ➝ $7.00 | Outperform ➝ Outperform | |
PCAR PACCAR | Initiated by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $102.94 -1.0% | | Market Perform | |
PCVX Vaxcyte | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $75.51 -4.1% | $95.00 ➝ $95.00 | Buy ➝ Buy | |
PD Precision Drilling | Target Lowered by | ATB Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | C$96.20 -0.3% | C$126.00 ➝ C$120.00 | Outperform | |
PD PagerDuty | Initiated by | Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating | N. Altmann Subscribe to MarketBeat All Access for the recommendation accuracy rating | $22.93 +0.7% | $23.00 | Sector Perform | |
PFG Principal Financial Group | Target Raised by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $78.45 -1.3% | $74.00 ➝ $78.00 | Hold ➝ Hold | |
PH Parker-Hannifin | Initiated by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $505.81 +0.3% | $610.00 | Outperform | |
PHAT Phathom Pharmaceuticals | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.30 -1.0% | $26.00 ➝ $26.00 | Buy ➝ Buy | |
PHX PHX Energy Services | Target Lowered by | ATB Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | C$9.07 -0.1% | C$12.25 ➝ C$11.75 | Outperform | |
PRI Primerica | Target Raised by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $236.58 +0.1% | $235.00 ➝ $236.00 | Hold ➝ Hold | |
PRU Prudential Financial | Target Lowered by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $117.19 -0.1% | $143.00 ➝ $141.00 | Buy ➝ Buy | |
PYPL PayPal | Reiterated by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.03 -0.6% | $84.00 ➝ $84.00 | Outperform ➝ Outperform | |
QST Questor Technology | Target Raised by | ATB Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | C$0.51 +2.0% | C$0.60 ➝ C$0.65 | Sector Perform | |
RAIL FreightCar America | Upgraded by | Noble Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Reichman Subscribe to MarketBeat All Access for the recommendation accuracy rating | $3.49 -4.6% | | Strong-Buy | |
RBC RBC Bearings | Initiated by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $269.78 -0.5% | | Market Perform | |
RCKT Rocket Pharmaceuticals | Target Lowered by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.53 +0.5% | $53.00 ➝ $52.00 | Buy ➝ Buy | |
RCKT Rocket Pharmaceuticals | Reiterated by | Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.53 +0.5% | $62.00 ➝ $62.00 | Buy ➝ Buy | |
RCM R1 RCM | Reiterated by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.56 +0.5% | $19.00 ➝ $19.00 | Outperform ➝ Outperform | |
RGA Reinsurance Group of America | Target Raised by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $205.27 -0.4% | $240.00 ➝ $247.00 | Buy ➝ Buy | |
RGA Reinsurance Group of America | Target Raised by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $205.27 -0.4% | $228.00 ➝ $235.00 | Overweight ➝ Overweight | |
RIVN Rivian Automotive | Target Raised by | DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.42 -7.3% | $12.00 ➝ $13.00 | Neutral ➝ Neutral | |
RIVN Rivian Automotive | Target Raised by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.42 -7.3% | $13.00 ➝ $20.00 | Buy ➝ Buy | |
RIVN Rivian Automotive | Target Raised by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.42 -7.3% | $10.00 ➝ $17.00 | Neutral ➝ Neutral | |
RRX Regal Rexnord | Initiated by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $135.22 -0.6% | | Market Perform | |
RVTY Revvity | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $104.86 -0.8% | $116.00 ➝ $115.00 | Equal Weight ➝ Equal Weight | |
RWAY Runway Growth Finance | Initiated by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.76 -0.2% | $12.00 | Neutral | |
SAFE Safehold | Target Raised by | The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.29 +1.7% | $25.00 ➝ $29.00 | Buy ➝ Buy | |
SAGE Sage Therapeutics | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.86 +1.6% | | Hold | |
SBRY J Sainsbury | Reiterated by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | GBX 255 -0.8% | | Underweight | |
SBUX Starbucks | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $77.85 -1.8% | $81.00 ➝ $81.00 | Neutral ➝ Neutral | |
SE SEA | Reiterated by | Dbs Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $71.42 -4.1% | $75.00 | Buy ➝ Hold | |
SFM Sprouts Farmers Market | Target Raised by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $83.66 +2.4% | $68.00 ➝ $94.00 | Neutral ➝ Neutral | |
SGMT Sagimet Biosciences | Reiterated by | The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | A. Tan Subscribe to MarketBeat All Access for the recommendation accuracy rating | $3.42 -16.8% | $23.00 ➝ $6.00 | Buy ➝ Neutral | |
SGRY Surgery Partners | Initiated by | Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $23.79 -2.2% | $31.00 | Outperform | |
SLB Schlumberger | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $47.18 +0.4% | $65.00 ➝ $62.00 | Buy ➝ Buy | |
SLN Silence Therapeutics | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.00
| $45.00 ➝ $49.00 | Overweight ➝ Overweight | |
SLN Silence Therapeutics | Target Raised by | Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.00
| $42.00 ➝ $55.00 | Buy ➝ Buy | |
SLP Simulations Plus | Initiated by | William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Smock Subscribe to MarketBeat All Access for the recommendation accuracy rating | $48.62 +1.5% | | Outperform | |
SMPL Simply Good Foods | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $36.13 +1.2% | $41.00 ➝ $41.00 | Buy ➝ Buy | |
SNDX Syndax Pharmaceuticals | Initiated by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $20.53 +1.0% | $37.00 | Buy | |
SRP Serco Group | Target Raised by | Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | | GBX 179.70 -0.3% | GBX 200 ➝ GBX 205 | Hold | |
SSV Southern Silver Exploration | Target Set by | Fundamental Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | C$0.24
| C$0.60 | Buy | |
STLA Stellantis | Initiated by | Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.85 +0.4% | $23.50 | Market Perform | |
STOK Stoke Therapeutics | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.51 +1.5% | $22.00 ➝ $22.00 | Buy ➝ Buy | |
SYF Synchrony Financial | Initiated by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $47.19 +6.7% | $56.00 | Outperform | |
SYF Synchrony Financial | Upgraded by | Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating | B. Crowley Subscribe to MarketBeat All Access for the recommendation accuracy rating | $47.19 +6.7% | | Strong-Buy | |
T AT&T | Target Raised by | Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.11 +1.9% | $24.00 ➝ $26.00 | Buy ➝ Buy | |
TEX Terex | Initiated by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $54.84 +3.1% | | Market Perform | |
THC Tenet Healthcare | Target Raised by | Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $133.03 -3.8% | $150.00 ➝ $155.00 | Buy ➝ Buy | |
TKR Timken | Initiated by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $80.13 +0.3% | | Market Perform | |
TLNE Talen Energy | Reiterated by | BWS Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $111.02 +0.5% | $145.00 ➝ $145.00 | Buy ➝ Buy | |
TMO Thermo Fisher Scientific | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $553.00 +0.4% | $615.00 ➝ $600.00 | Equal Weight ➝ Equal Weight | |
TNR TNR Gold | Target Set by | Fundamental Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | C$0.06
| C$0.24 | Buy | |
TRUP Trupanion | Target Raised by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.40 -0.9% | $22.00 ➝ $30.00 | Neutral ➝ Neutral | |
TRV Travelers Companies | Reiterated by | William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $203.34 -1.7% | | Outperform ➝ Market Perform | |
TRV Travelers Companies | Reiterated by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Ward Subscribe to MarketBeat All Access for the recommendation accuracy rating | $203.34 -1.7% | $226.00 ➝ $200.00 | Neutral ➝ Sell | |
TSCO Tesco | Reiterated by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | GBX 306 -0.2% | | Underweight | |
TVGN Tevogen Bio | Target Set by | Fundamental Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.72 -1.4% | $4.20 | Buy | |
TWLO Twilio | Initiated by | Tigress Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $56.81 +1.5% | $75.00 | Buy | |
TWST Twist Bioscience | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $49.28 +3.8% | $45.00 ➝ $60.00 | Overweight ➝ Overweight | |
TXG 10x Genomics | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.45 -2.0% | $36.00 ➝ $24.00 | Overweight ➝ Overweight | |
UBER Uber Technologies | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $72.68 +3.3% | $89.00 ➝ $91.00 | Overweight ➝ Overweight | |
UFPT UFP Technologies | Target Raised by | Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $263.87 +2.4% | $270.00 ➝ $300.00 | Buy ➝ Buy | |
ULTA Ulta Beauty | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $385.87 0.0% | $394.00 ➝ $355.00 | Equal Weight ➝ Equal Weight | |
UNM Unum Group | Target Raised by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $51.11 +0.8% | $62.00 ➝ $63.00 | Buy ➝ Buy | |
URI United Rentals | Initiated by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $646.73 +3.8% | $750.00 | Outperform | |
VERX Vertex | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $36.05 +0.7% | $32.00 ➝ $36.00 | Neutral ➝ Neutral | |
VIGL Vigil Neuroscience | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.00 -10.7% | $24.00 ➝ $24.00 | Buy ➝ Buy | |
VIGL Vigil Neuroscience | Target Raised by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.00 -10.7% | $22.00 ➝ $23.00 | Outperform ➝ Outperform | |
VOYA Voya Financial | Target Raised by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $71.15 -0.2% | $76.00 ➝ $79.00 | Hold ➝ Hold | |
VRNA Verona Pharma | Target Raised by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.46 -6.3% | $32.00 ➝ $38.00 | Buy ➝ Buy | |
VSEC VSE | Initiated by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $88.28 +1.3% | $101.00 | Buy | |
WAT Waters | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $290.12 +1.3% | $295.00 ➝ $275.00 | Underweight ➝ Underweight | |
WBA Walgreens Boots Alliance | Reiterated by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.10 -0.7% | $22.00 ➝ $11.00 | Underperform ➝ Underperform | |
WBA Walgreens Boots Alliance | Target Lowered by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.10 -0.7% | $20.00 ➝ $13.00 | Hold ➝ Hold | |
WBA Walgreens Boots Alliance | Target Lowered by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.10 -0.7% | $13.00 ➝ $9.00 | Underweight ➝ Underweight | |
WBA Walgreens Boots Alliance | Target Lowered by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.10 -0.7% | $17.00 ➝ $10.00 | In-Line ➝ In-Line | |
WEST Westrock Coffee | Reiterated by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.23 -0.5% | $14.00 ➝ $14.00 | Outperform ➝ Outperform | |
WK Workiva | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $72.99 -0.7% | $103.00 ➝ $105.00 | Buy ➝ Buy | |
WOSG Watches of Switzerland Group | Target Raised by | Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | | GBX 414 -2.2% | GBX 420 ➝ GBX 435 | Hold | |
WPP WPP | Reiterated by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | GBX 724.40 -2.2% | | Buy | |
WPP WPP | Target Lowered by | Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | | GBX 724.40 -2.2% | GBX 998 ➝ GBX 990 | Buy | |
WSR Whitestone REIT | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.31 +2.5% | $15.00 ➝ $15.00 | Market Outperform ➝ Market Outperform | |
WULF TeraWulf | Target Raised by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.45 +0.9% | $5.00 ➝ $6.00 | Buy ➝ Buy | |
XFOR X4 Pharmaceuticals | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.58 -13.4% | $5.00 ➝ $5.00 | Buy ➝ Buy | |
XRX Xerox | Initiated by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.62 -3.5% | $11.00 | Sell | |
YMAB Y-mAbs Therapeutics | Initiated by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | N. Germino Subscribe to MarketBeat All Access for the recommendation accuracy rating | $12.08 -2.0% | $21.00 | Buy | |